Caponigro, F.
20  results:
Search for persons X
?
 
?
 
?
3

A CT-based radiomic signature can be prognostic for 10-mont..:

Corino V. D. A ; Bologna M ; Calareso G...
info:eu-repo/semantics/altIdentifier/wos/WOS:000667504200001.  , 2021
 
?
4

Management of recurrent nasopharyngeal carcinoma: current p..:

Perri, F ; Della Vittoria Scarpati, G ; Caponigro, F...
info:eu-repo/semantics/altIdentifier/doi/10.2147/OTT.S188148.  , 2019
 
?
5

Management of recurrent nasopharyngeal carcinoma: current p..:

Perri F ; Della Vittoria Scarpati G ; Caponigro F...
https://www.dovepress.com/management-of-recurrent-nasopharyngeal-carcinoma-current-perspectives-peer-reviewed-article-OTT.  , 2019
 
?
9

Phase I dose-escalation study of brostallicin, a minor groo..:

Caponigro, F ; Lorusso, D ; Fornari, G...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00280-009-1175-6.  , 2009
 
?
10

Multicentre EORTC study 16997: feasibility and phase II tri..:

Theodore, C ; Geoffrois, L ; Vermorken, J.B...
Theodore , C , Geoffrois , L , Vermorken , J B , Caponigro , F , Fiedler , W , Chollet , P , Ravaud , A , Peters , G J , de Balincourt , C , Lacombe , D & Fumoleau , P 2005 , ' Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers ' , European Journal of Cancer , vol. 41 , no. 8 , pp. 1150-1157 . https://doi.org/10.1016/j.ejca.2005.02.015.  , 2005
 
?
11

Percorso diagnostico, terapeutico e assistenziale per i tum..:

V. Valentini ; L. Preda ; F. Ballati...
ispartofbook:Percorso diagnostico, terapeutico e assistenziale per i tumori di testa e collo – Aggiornamento 2020 AIOCC.  , 2020
 
?
12

The ubiquitin–proteasome system as a molecular target in so..:

A Milano ; F Perri ; F Caponigro
http://www.dovepress.com/the-ubiquitinndashproteasome-system-as-a-molecular-target-in-solid-tum-a3315.  , 2009
 
?
 
1-15